Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.
- Resource Type
- Letter
- Authors
- Landmeier, S.; Altvater, B.; Pscherer, S.; Meltzer, J.; Sebire, N.; Pule, M.; Vera, J.; Hotfilder, M.; Juergens, H.; Vormoor, J.; Rossig, C.
- Source
- Leukemia (08876924). May2010, Vol. 24 Issue 5, p1080-1084. 5p. 2 Graphs.
- Subject
- *LETTERS to the editor
*LYMPHOBLASTIC leukemia
*CANCER relapse
- Language
- ISSN
- 0887-6924
A letter to the editor is presented related to favorable outcomes of Hematopoietic stem cell transplantation (HSCT) in recurrent acute lymphoblastic leukemia.